MedPath

Whole Body Vibration - a New Therapeutic Approach to Improve Muscle Function in CF

Not Applicable
Completed
Conditions
Cystic Fibrosis
Registration Number
NCT00388466
Lead Sponsor
University of Cologne
Brief Summary

The purpose of this study is to evaluate the effects of whole body vibration (WBV) on muscle function in adult CF-patients.

Detailed Description

Cystic Fibrosis (CF) is the most common chronic hereditary disease in Caucasians. Due to improved therapy and better understanding of the disease, life expectancy has risen to an average of 38 years and is continuing to rise. With the increased life-expectancy it becomes even more important to maintain functional activity as part of quality of life. Mechanical stimulation in form of whole body vibration (WBV) is a new type of exercise currently tested in sports, geriatrics and rehabilitation. It has recently been found to be a safe and efficient method to activate muscular activity via stretch reflexes leading to improvement of muscular performance, body balance and physical functioning.

10 patients of the CF Center Cologne, Germany, took part in the Galileo study. They were provided by the vibrating platform (Galileo 2000)for whole body vibration training at home. The patients were standing in an upright position receiving vertical vibration of frequencies between 20-25 Hz. This vibration exercise evokes muscle contractions via stretch reflexes improving muscular activity. The training schedule consisted of three 3-minute sessions twice a day 5 days per week for 3 months.

Every 4 weeks the patients were seen for assessment of muscle function to evaluate the effects of this new intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • clinical diagnosis of Cystic Fibrosis
  • age older than 18 years
Exclusion Criteria
  • hypersplenic syndrome
  • acute arthritis or osteomyelitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
muscle force at the beginning of the study and after 3 months
muscle power at the beginning of the study and after 3 months
Secondary Outcome Measures
NameTimeMethod
pulmonary function testing at the beginning of the study and after 3 months

Trial Locations

Locations (1)

CF Center Cologne, University Children's Hospital

🇩🇪

Cologne, Germany

CF Center Cologne, University Children's Hospital
🇩🇪Cologne, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.